Live Breaking News & Updates on Manfred Spraul

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities
on May 21 2021 12:12 AM
Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of
Post-Acute COVID-19 Syndrome (PACS)
PERTH, Australia (BUSINESS WIRE) A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase. These biochemical abnormalities, identified by a quantitative, label-free assay platform integrating nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), relate to ongoing ‘long COVID’ symptoms, which persist post-acute infection and can affect more than half of the recovered COVID patients - even six months after infection. ....

Western Australia , Pais Vasco , Miroslava Minkova , Bruker Biospin , Elaine Holmes , Julien Wist , Jeremy Nicholson , Nathang Lawler , Manfred Spraul , Thorsten Thiel , Group Marketing , Severo Ochoa Center , Mccusker Foundation , Murdoch University , Health Futures Institute At Murdoch University , Bruker Corporation Nasdaq , International Phenome Centre Network , Journal Of Proteome Research , Australian National Phenome Centre , Corporate Development , Clinical Division , Gune Research Center , Spinnaker Health Research Foundation , Technology Park , Australian National Phenome Centre Integrates Quantitative , Risk Assessment ,